Emerg Infect Dis by Collignon, Peter et al.
LETTERS
Address for correspondence: Jun Zhang, 
Department of Clinical Laboratory Medicine, 
Shanghai Public Health Clinical Center, Fudan 
University, 2901 Caolang Rd, Jinshan District, 
Shanghai, China; email: zhangjun@shaphc.org




To the Editor: Globally, antimi-
crobial drug resistance is rapidly ris-
ing, with resultant increased illness 
and death. Of particular concern is 
Escherichia coli, the most common 
bacterium to cause invasive disease 
in humans (1). In Europe, increasing 
proportions of bloodstream infections 
caused by E. coli are resistant to third-
generation cephalosporins (1,2).
Resistant E. coli can be transmit-
ted to humans from animals. A large 
proportion of resistant isolates caus-
ing human infections are derived from 
food animals (3–6). However, lack of 
data has made it difficult to quantify the 
proportion of antimicrobial drug resis-
tant E. coli infecting persons through 
food sources and the resultant effects 
on human health. Recent data from the 
Netherlands now make such estimates 
possible (2,6). The additional illness 
and death among humans resulting 
from bloodstream infections caused by 
third-generation cephalosporin–resis-
tant E. coli (G3CREC) has been cal-
culated for Europe (2). In the Nether-
lands, there were 205 G3CREC cases 
during 2007 (4% of all E. coli blood-
stream infections) (2). Another study 
in the Netherlands revealed that 56% 
of the resistance genes in G3CREC 
in humans were identical to genes de-
rived from E. coli isolated from retail 
chicken samples (6). Using the find-
ings of Overdevest et al. (6) and de 
Kraker et al. (2), we calculated that, in 
the Netherlands, infections in humans 
with G3CREC derived from poultry 
sources were associated with 21 addi-
tional deaths. G3CREC-related illness 
also resulted in 908 hospital bed-days 
needed to treat persons with these an-
timicrobial drug resistant bloodstream 
infections. If these values were extrap-
olated to all of Europe (i.e., if 56% of 
G3CREC were derived from poultry), 
1,518 additional deaths and an associ-
ated increase of 67,236 days of hospi-
tal admissions would be counted as a 
result of cephalosporin and other anti-
microbial drug use in poultry.
To more accurately estimate the 
associated increased deaths among per-
sons resulting from third-generation 
cephalosporin use in poultry, detailed 
data from more countries is essential. 
Needed data include records of antimi-
crobial drug use and resistant bacterial 
strains found in food animals and do-
mestic and imported foods. However, 
we already know that G3CREC is 
rapidly rising in many countries, and 
in Europe, the infection rate is likely 
to have tripled from 2007 to 2012 (2). 
Globally, billions of chickens receive 
third-generation cephalosporins in ovo 
or as day-old chicks to treat E. coli in-
fection, a practice that has resulted in 
large reservoirs of resistant bacteria. 
In Canada, this practice has been as-
sociated with substantial increases in 
resistance to third-generation cepha-
losporins in Salmonella enterica se-
rovar Heidelberg isolates detected in 
humans. (7). The United States Food 
and Drug Administration recently pro-
hibited the off-label use of cephalo-
sporins, including prophylactic uses, 
in major food animal species, includ-
ing poultry (8).
The number of avoidable deaths 
and the costs of health care potentially 
caused by third-generation cepha-
losporin use in food animals is stag-
gering. Considering those factors, the 
ongoing use of these antimicrobial 
drugs in mass therapy and prophy-
laxis should be urgently examined and 
stopped, particularly in poultry, not 
only in Europe, but worldwide.
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To the Editor: In Malaysia, the 
only histologically diagnosed autoch-
thonous cases of human schistosomia-
sis were reported in the 1970s, all in 
rural aborigine (Orang Asli) popula-
tions (1–3) (online Technical Appen-
dix Figure 1, wwwnc.cdc.gov/EID/
article/19/8/12-1710-Techapp1.pdf). 
The fact that the infection had been 
found only among aborigines had led 
to the proposal of a distinct unknown 
schistosome with an animal reservoir 
causing sylvatic infections (2,3). Con-
sequently, during the 1980s, Schisto-
soma malayensis n. sp. was described 
from intermediate snail (Robertsiella 
sp.) and final mammalian hosts (Rat-
tus muelleri and R. tiomanicus [4]). 
S. malayensis is closely related to S. 
mekongi and differs genetically from 
the latter by ≈10%. Both species dif-
fer from S. japonicum by 25% (5), and 
adult and ova morphologies are simi-
lar (4). Few transmission sites for this 
new S. japonicum–complex schisto-
some species were identified in rural 
areas (4). We report after 30 years the 
histologic finding of S. malayensis–
like eggs in the liver of a Malay man 
and discuss public health implications.
A 29-year-old male nonaboriginal 
Malay from Subang Jaya in Selangor 
State, Peninsular Malaysia, had died 
suddenly of an intoxication in 2011. 
According to his mother, he had re-
ported hematuria and dysuria during 
adolescence. Similar symptoms had 
reoccurred 10 years later, accom-
panied by constipation. The patient 
had never been outside of Malaysia, 
and he had gone bomb fishing for 
many years in Sungai Lepar Utara, a 
river near his village (Felda Tekam 
Utara, Jerantut, Pahang; 3°52’30”N, 
102°49’2”E). No tests on blood or fe-
ces were performed before his death. 
An autopsy was conducted in Sungai 
Buloh Hospital, and gross pathology 
showed a normal heart, kidneys, and 
brain. The lungs were edematous and 
congested. The liver also was con-
gested, but no macroscopic lesions 
were seen. Toxicology investigations 
showed methadone and a derivative in 
his blood and urine. During a routine 
histologic examination, several gran-
ulomas with intensive lymphocyte, 
monocyte, and eosinophil infiltration 
surrounding clusters of ovoidal eggs 
were found in the liver (Figure; online 
Technical Appendix Figure 2). Serial 
sectioning showed that the eggs con-
tained miracidia and had the overall 
appearance of S. malayensis–like ova 
50 µm long × 28 µm wide. The ova 
were not operculated and had no bipo-
lar plugs; the thin yellowish shell was 
not striated, but a knob-like structure 
was seen laterally. Morphologic dif-
ferential diagnoses included eggs of 
Capillaria hepatica (bipolar striated 
ova in liver), Dicrocoelium (slightly 
smaller operculated ova typically 
found in feces or bile), and the similar 
Eurytrema (thick-walled operculated 
ova in feces).
Schistosomiasis is endemic in 
many developing countries and in-
fects >207 million persons living in 
rural agricultural areas (6). In Asia, 
S. japonicum, S. mekongi, and S. ma-
layensis cause human infection (7), 
with S. japonicum being the most 
dangerous. In Malaysia, S. malayen-
sis, in addition to S. spindale, S. na-
sale, S. incognitum, Trichobilhazia 
brevis, and Pseudobilharziella lon-
churae, is known to occur in wildlife 
(8). The first known case of human 
schistosomiasis in Malaysia was dis-
covered in 1973 during an autopsy 
of an aborigine. Schistosoma eggs 
resembling those of S. japonicum 
were found in liver tissue (1). A sub-
sequent retrospective autopsy study 
revealed additional cases with these 
Schistosoma japonicum–like ova in 
the rural aboriginal population, re-
sulting in an overall prevalence of 
3.9% (2). Several attempts to recover 
eggs from feces from the Orang Asli 
population in peninsular Malaysia 
(3), a biopsy-positive Orang Asli (3), 
and serologically positive persons 
(9, and others) were unsuccessful, 
however, which was attributed to the 
zoonotic nature of S. malayensis and 
thus missing adaptation to the human 
host. Whether hematuria, a typical 
sign of S. haematobium infection, as 
seen in the patient reported here also 
was caused by S. malayensis disease 
remains unclear because symptoms 
of the latter have not been reported. 
Serologic surveys for schistosomia-
sis in peninsular Malaysia showed 
prevalences of 4%–25% in selected 
rural populations (9). Because infect-
ed Robertsiella snails had been found 
almost exclusively in small rivers 
(4,9–habitats like the Sungai Lepar 
Utara River in our current report–we 
suspect that the patient most likely 
became infected while fishing. The 
travel history may not be accurate 
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